Par Pharmaceutical, Inc. recalls Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by:
Par Pharmaceutical recalls 30-count 0.75mg Pramipexole dihydrochloride extended release tablets with impurities that may affect safety. Check NDC 10370-252-11 and lot numbers for affected batches.
Recall notice
Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.
Contact the company & request your remedy
What happened, in plain English
Par Pharmaceutical is recalling 0.75mg Pramipexole dihydrochloride extended release tablets that contain impurities. This could affect the safety of the medication if taken as prescribed. Read more at govinfonow.com/recall/39658-par-pharmaceutical-recalls-0-75mg-pramipexole-tablets-due-to-impurities.
Source Summary by GovInfoNow · govinfonow.com/recall/39658-par-pharmaceutical-recalls-0-75mg-pramipexole-tablets-due-to-impurities · Updated October 6, 2026 · FDA enforcement record: FDA #D-1185-2018
Cite this page
“Par Pharmaceutical recalls 0.75mg Pramipexole tablets due to impurities.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39658-par-pharmaceutical-recalls-0-75mg-pramipexole-tablets-due-to-impurities. Based on FDA recall #D-1185-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1185-2018%22&limit=1).
Why it’s dangerous
The tablets contain a known impurity that may exceed current safety specifications. This could potentially affect the medication's safety when taken as prescribed.
Who’s affected
Prescription patients using the recalled 0.75mg Pramipexole tablets. Those with specific lot numbers and NDC codes are most at risk.
How to tell if you have this one
Check for the NDC code 10370-252-11 and lot numbers 29906202 (exp 12/18), 29993102 (exp 2/19), 30366102/30373103 (exp 4/19), or 31940601 (exp 3/20).
- Brand
Par Pharmaceutical- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 10370-252-11 and specific lot numbers listed in the recall notice.
Questions people ask
Is this product safe to use?
The recall states the product contains impurities that may affect safety, but no specific remedy is provided. Consult your doctor for guidance.
What lot numbers are affected?
Lot numbers 29906202 (exp 12/18), 29993102 (exp 2/19), 30366102/30373103 (exp 4/19), and 31940601 (exp 3/20).
Do I need to stop using this product?
The recall does not specify a stop-use instruction, so consult your doctor to determine if you should stop using it.
Contact Par Pharmaceutical
We’ve drafted a message you can send Par Pharmaceutical to request your refund or repair — edit it as you like.
Subject: Recall D-1185-2018 — Par Pharmaceutical Par Pharmaceutical Hello, I own a Par Pharmaceutical that is covered by recall D-1185-2018 from Par Pharmaceutical. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1185-2018 (September 6, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1185-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.